| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,675 | 23,966 | 21,201 | 56,680 | | Cost of Revenue | 29,567 | 18,675 | 16,038 | 42,394 | | | Gross Profit | 9,108 | 5,291 | 5,162 | 14,286 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (726) | 2,135 | 2,147 | 5,668 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,036 | 3,156 | 3,015 | 8,618 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | 156 | 68 | 240 | | Earnings Before Interest And Taxes | 7,051 | 3,311 | 3,083 | 8,858 | | Interest Expense | 857 | 745 | 604 | 869 | | Income Before Tax | 6,194 | 2,566 | 2,479 | 7,989 | | Income Tax Expense | 1,397 | 603 | 581 | 1,215 | | Minority Interest |
-
| 142 | (142) | (379) | | | | Net Income From Continuing Ops | (3,862) | 2,106 | 1,756 | 6,396 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,798 | 2,106 | 1,756 | 6,396 | | Preferred Stock And Other Adjustments | 250 | (250) |
-
|
-
| | | Net Income Applicable To Common Shares | $5,048 | $1,856 | $1,756 | $6,396 |
|
0.13% Nasdaq 
0.10%
Income Statement
